|Johannes Niessing (Chair)||Boehringer Ingelheim, Germany|
|Helen Harbrow||IQVIA, UK|
|Ingrid Collomb Clerc||BD Medical, France|
The Committee meets annually to:
Discuss developments in dosage forms and delivery systems
Agree on new, changed and deleted NFC classes for the ongoing development of the NFC system
Agree requests for NFC changes for specific products
Please contact the Committee: To discuss issues relating to the NFC Classification System.
Perhaps you have a new dosage form and would like to know how it would be classified or if it will receive a new NFC? Then Contact Us.